2014
DOI: 10.1016/j.healthpol.2014.06.001
|View full text |Cite
|
Sign up to set email alerts
|

Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
32
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(39 citation statements)
references
References 43 publications
3
32
0
Order By: Relevance
“…The country large study by Vogler et al (2014) reveals that in countries having adopted deregulation policies (in primis Norway and Sweden, but also England, The Netherlands and Ireland) the number of pharmacies increased. However, the newly opened pharmacies were mostly concentrated in urban areas, which already had a high number of pharmacies in the pre-reform period, while no indications of improved accessibility in rural areas were found.…”
Section: Deregulation and Spatial Accessibility To Community Pharmaciesmentioning
confidence: 99%
See 1 more Smart Citation
“…The country large study by Vogler et al (2014) reveals that in countries having adopted deregulation policies (in primis Norway and Sweden, but also England, The Netherlands and Ireland) the number of pharmacies increased. However, the newly opened pharmacies were mostly concentrated in urban areas, which already had a high number of pharmacies in the pre-reform period, while no indications of improved accessibility in rural areas were found.…”
Section: Deregulation and Spatial Accessibility To Community Pharmaciesmentioning
confidence: 99%
“…Indeed, access to primary healthcare in the Province of Cuneo in Piedmont, Italy has been found to be lower in its mountainous areas than in the plains (Perez and Decoupigny, 2009). To guarantee more equitable access to pharmaceuticals, single nations have adopted different legislative and regulatory strategies (WHO, 2001;Vogler et al, 2014). In Italy, a new deregulatory reform became law (Italian Republic, 2012) in 2012.…”
Section: Introductionmentioning
confidence: 99%
“…Pharmacist partnership is allowed in many countries such as United States, Ireland, Netherlands, Norway, England, Sweden and Iceland. 4,6,7 In some countries like Spain, Finland, Austria, Denmark, Belgium, France, Portugal and Italy pharmacist partnership is only permitted under certain conditions. Beside to this, pharmacist partnership is not allowed in countries, which have restrictive regulations about pharmacy ownership such as Germany and Turkey.…”
Section: Introductionmentioning
confidence: 99%
“…3 The competitive structure of community pharmacy sector might prompt pharmacists to pay attention for business issues more than health issues. 7 Similar to all businesses, community pharmacists must protect their profitability to continue their profession functions. In this context, partnerships are thought as a solution for taking market advantage in community pharmacy sector.…”
Section: Introductionmentioning
confidence: 99%
“…Health economics and therapeutic pathways 2015; 16 (1) Impact of new healthcare legislation and price policy on healthcare services provider at the time of financial crisis. A 10 years study economic pressure [5]. Furthermore, healthcare market has been deregulated in such a way that revenues are diminished for the new participants entering the market.…”
Section: Introductionmentioning
confidence: 99%